Credit Suisse’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-41,518
Closed -$622K 3166
2023
Q3
$622K Sell
41,518
-2,490
-6% -$51.8K ﹤0.01% 2568
2023
Q2
$1.43M Sell
44,008
-6,510
-13% -$238K ﹤0.01% 2145
2023
Q1
$1.98M Buy
50,518
+10,157
+25% +$497K ﹤0.01% 1880
2022
Q4
$2.13M Buy
40,361
+10,013
+33% +$488K ﹤0.01% 1828
2022
Q3
$1.37M Buy
30,348
+5,095
+20% +$219K ﹤0.01% 2101
2022
Q2
$918K Buy
25,253
+719
+3% +$26.1K ﹤0.01% 2457
2022
Q1
$1.01M Buy
24,534
+1,822
+8% +$64.1K ﹤0.01% 2536
2021
Q4
$967K Sell
22,712
-1,653
-7% -$82.7K ﹤0.01% 3344
2021
Q3
$1.34M Buy
24,365
+4,127
+20% +$216K ﹤0.01% 3112
2021
Q2
$968K Sell
20,238
-5,555
-22% -$283K ﹤0.01% 3413
2021
Q1
$1.3M Sell
25,793
-10,901
-30% -$606K ﹤0.01% 3133
2020
Q4
$2.31M Buy
36,694
+11,205
+44% +$695K ﹤0.01% 2712
2020
Q3
$1.71M Sell
25,489
-824
-3% -$45K ﹤0.01% 2531
2020
Q2
$1.1M Buy
26,313
+15,946
+154% +$612K ﹤0.01% 2823
2020
Q1
$326K Sell
10,367
-3,893
-27% -$156K ﹤0.01% 3379
2019
Q4
$575K Sell
14,260
-13,090
-48% -$458K ﹤0.01% 3478
2019
Q3
$889K Buy
+27,350
New +$1.09M ﹤0.01% 3084

Other funds holding SILK

Credit Suisse's SILK Position: Q4 2023 in Review

Credit Suisse sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q4 2023, closing a stake of 41,518 shares — an estimated $622K sold.

Credit Suisse first reported a position in SILK in Q3 2019 and held it in 17 quarters. The position peaked at $2.31M in Q4 2020. 133 funds tracked by Wall St. Rank hold SILK as of Q4 2023.

  • Credit Suisse reported no remaining Silk Road Medical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Credit Suisse sold 41,518 Silk Road Medical, Inc. Common Stock shares in Q4 2023, an estimated $622K.
  • Credit Suisse first reported a position in Silk Road Medical, Inc. Common Stock in Q3 2019 and held it in 17 quarters.
  • Credit Suisse's Silk Road Medical, Inc. Common Stock position peaked at $2.31M in Q4 2020.
  • 133 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q4 2023.

Based on Credit Suisse's 13F filing for Q4 2023, filed 8 Feb 2024.